Document is current

Any future updates will be listed below

Can we predict the development of serious adverse events (SAEs) and early treatment termination in elderly non-small cell lung cancer (NSCLC) patients receiving platinum-based chemotherapy?

Crossref DOI link: https://doi.org/10.1007/s00432-016-2170-z

Published Online: 2016-05-11

Published Print: 2016-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark